Cited by 3,738PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Oncogenic kinase signalling.

Blume-Jensen, Peter, Hunter, Tony·2001·Nature

DOI 10.1038/35077225

Open this paper in CoChat — free account

Abstract

Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans. Their activity is normally tightly controlled and regulated. Perturbation of PTK signalling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation. The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signalling. This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signalling in human malignancies.

Integrity signals

Registry

Crossref · 10.1038/35077225

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Signaling—2000 and Beyond
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Self-citation

Flagged first, then by citations

Show all 93 references

Research works printed but not linked: 3

Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).
Blume-Jensen, P. & Hunter, T. in Cancer Research - An Encyclopedic Reference (ed. Schwab, M.) (Springer, in the press).
Blume-Jensen, P. & Hunter, T. in Encyclopedia of Cancer (ed. Bertino, J. R.) (Academic, San Diego, in the press).

Sorted by citations

Items 901–1,000 of 1,008

Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: Findings from 3-D melanoma skin equivalents and computational modeling
Syed, D. N., Chamcheu, J. C., Khan, M. I., Sechi, M., Lall, R. K., Adhami, V. M., & Mukhtar, H. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.03.007 · Cited by 65
Targeting Phosphatases and Kinases: How to Checkmate Cancer
Turdo, A., D’Accardo, C., Glaviano, A., Porcelli, G., Colarossi, C., Colarossi, L., Mare, M., Faldetta, N., Modica, C., Pistone, G., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.690306 · Cited by 66
Emerging functions of c-kit and its ligand stem cell factor in dendritic cells
Ray, P., Krishnamoorthy, N., & Ray, A. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6752 · Cited by 65
Signaling of c‐kit in dendritic cells influences adaptive immunity
Ray, P., Krishnamoorthy, N., Oriss, T. B., & Ray, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05122.x · Cited by 67
Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytes
Kim, W. K., Jung, H., Kim, D.-H., Kim, E. Y., Chung, J. W., Cho, Y. S., Park, S.-G., Park, B.-C., Ko, Y., Bae, K., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.053009 · Cited by 67
Putative Phosphatidylinositol 3-Kinase (PI3K) Binding Motifs in Ovine Betaretrovirus Env Proteins Are Not Essential for Rodent Fibroblast Transformation and PI3K/Akt Activation
Liu, S., Lerman, M. I., & Miller, A. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7924-7935.2003 · Cited by 65
Identification and characterization of molecular targets of natural products by mass spectrometry
Cheng, K., Wong, C.-C., Wang, M., He, Q., & Chen, F. (2009) · Mass Spectrometry Reviews · doi:10.1002/mas.20235 · Cited by 65
Mass Spectrometry Mapping of Epidermal Growth Factor Receptor Phosphorylation Related to Oncogenic Mutations and Tyrosine Kinase Inhibitor Sensitivity
Zhang, G., Fang, B., Liu, R. Z., Lin, H., Kinose, F., Bai, Y., Oguz, U., Remily-Wood, E. R., Li, J., Altiok, S., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr1006203 · Cited by 64
ROS receptor tyrosine kinase: a new potential target for anticancer drugs
El-Deeb, I. M., Yoo, K. H., & Lee, S. H. (2010) · Medicinal Research Reviews · doi:10.1002/med.20206 · Cited by 65
Smad linker region phosphorylation in the regulation of extracellular matrix synthesis
Burch, M. L., Zheng, W., & Little, P. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0514-4 · Cited by 65
Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides
Matsushita, C., Tamagaki, H., Miyazawa, Y., Aimoto, S., Smith, S. O., & Sato, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215207110 · Cited by 67
Tyrosine kinase signaling and the emergence of multicellularity
Miller, W. T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.03.009 · Cited by 69
Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells
Zheleznova, N. N., Wilson, P. D., & Staruschenko, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.004 · Cited by 62
Complex Multicellular Systems and Immune Competition: New Paradigms Looking for a Mathematical Theory
Bellomo, N., & Forni, G. (2007) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)81017-9 · Cited by 65
LOOKING FOR NEW PARADIGMS TOWARDS A BIOLOGICAL-MATHEMATICAL THEORY OF COMPLEX MULTICELLULAR SYSTEMS
Bellomo, N., & Forni, G. (2006) · Mathematical Models and Methods in Applied Sciences · doi:10.1142/s0218202506001443 · Cited by 65
Pathology of the Future: Molecular Profiling for Targeted Therapy
Espina, V. A., Geho, D. H., Mehta, A. I., Petricoin, E. F., Liotta, L. A., & Rosenblatt, K. P. (2005) · Cancer Investigation · doi:10.1081/cnv-46434 · Cited by 65
Disruption of protein–protein interactions using nanoparticles: inhibition of cytochrome c peroxidase
Bayraktar, H., Ghosh, P. S., Rotello, V. M., & Knapp, M. J. (2006) · Chemical Communications · doi:10.1039/b516096k · Cited by 65
Epidermal Growth Factor Enhances Cellular TATA Binding Protein Levels and Induces RNA Polymerase I- and III-Dependent Gene Activity
Zhong, S., Zhang, C., & Johnson, D. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5119-5129.2004 · Cited by 65
Cancer immunoprevention: tracking down persistent tumor antigens
Lollini, P., & Forni, G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00030-3 · Cited by 66
Fibroblast Growth Factor Receptor and Platelet-Derived Growth Factor Receptor Abnormalities in Eosinophilic Myeloproliferative Disorders
Cross, N. C. P., & Reiter, A. (2008) · Acta Haematologica · doi:10.1159/000140631 · Cited by 64
Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction
Lamb, R., Harrison, H., Smith, D. L., Townsend, P. A., Jackson, T., Ózsvári, B., Martinez‐Outschoorn, U., Pestell, R. G., Howell, A., Lisanti, M. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3278 · Cited by 63
Unique Substrate Specificity of Anaplastic Lymphoma Kinase (ALK): Development of Phosphoacceptor Peptides for the Assay of ALK Activity
Donella‐Deana, A., Marin, O., Cesaro, L., Gunby, R. H., Ferrarese, A., Coluccia, A. M. L., Tartari, C. J., Mologni, L., Scapozza, L., Gambacorti-Passerini, C. B., et al. (2005) · Biochemistry · doi:10.1021/bi0472954 · Cited by 64
mTOR in renal cell cancer: modulator of tumor biology and therapeutic target
Wysocki, P. J. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.8 · Cited by 64
AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells
Wang, S., Yang, Q., Fung, K.-M. A., & Lin, H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.04.004 · Cited by 65
Electrochemical detection of protein tyrosine kinase-catalysed phosphorylation using gold nanoparticles
Kerman, K., & Kraatz, H. (2008) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.10.024 · Cited by 64
Small Molecule Substrate Phosphorylation Site Inhibitors of Protein Kinases: Approaches and Challenges
Breen, M. E., & Soellner, M. B. (2014) · ACS Chemical Biology · doi:10.1021/cb5008376 · Cited by 66
Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
Moschetta, M., Basile, A., Ferrucci, A., Frassanito, M. A., Rao, L., Ria, R., Solimando, A. G., Giuliani, N., Boccarelli, A., Fumarola, F., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0039 · Cited by 64
Phosphorylation-mediated activation of mouse Xkr8 scramblase for phosphatidylserine exposure
Sakuragi, T., Kosako, H., & Nagata, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820499116 · Cited by 66
Somatic Mutations of ErbB4
Tvorogov, D., Sundvall, M., Kurppa, K. J., Hollmén, M., Repo, S., Johnson, M. S., & Elenius, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805438200 · Cited by 64
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
Ke, H., Kazi, J. U., Zhao, H., & Sun, J. (2016) · Cell & Bioscience · doi:10.1186/s13578-016-0120-8 · Cited by 63
Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock, K., Küppers, R., Renné, C., Brune, V., Eckerle, S., Weidmann, E., Bräuninger, A., & Hansmann, M. (2006) · PubMed · Cited by 63
Synthesis and biological evaluation of a triazole-based library of pyrido[2,3-d]pyrimidines as FGFR3 tyrosine kinase inhibitors
Corre, L. L., Girard, A., Aubertin, J., Radvanyi, F., Benoist-Lasselin, C., Jonquoy, A., Dambroise, E., Legeai‐Mallet, L., Busca, P., & Merrer, Y. L. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/b923882d · Cited by 63
Loss of CD4 T-cell–dependent tolerance to proteins with modified amino acids
Gauba, V., Grünewald, J., Gorney, V., Deaton, L. M., Kang, M., Bursulaya, B. D., Ou, W., Lerner, R. A., Schmedt, C., Geierstanger, B. H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110042108 · Cited by 63
Tyrosine Kinase Inhibitors in Pulmonary Arterial Hypertension: A Double-Edge Sword?
Godinas, L., Guignabert, C., Seferian, A., Perros, F., Bergot, E., Sibille, Y., Humbert, M. J. C., & Montani, D. (2013) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0033-1356494 · Cited by 67
Overcoming Drug Resistance in Patients with Metastatic Breast Cancer
Wong, S. T.-L., & Goodin, S. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.8.954 · Cited by 63
Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents
Boone, J. J. M., Bhosle, J., Tilby, M. J., Hartley, J. A., & Hochhauser, D. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0219 · Cited by 64
Design, synthesis, and anticancer activity of novel 4-thiazolidinone-phenylaminopyrimidine hybrids
Türe, A., Ergül, M., Ergül, M., Altun, A., & Küçükgüzel, İ. (2020) · Molecular Diversity · doi:10.1007/s11030-020-10087-1 · Cited by 63
Zirconium(IV)-IMAC Revisited: Improved Performance and Phosphoproteome Coverage by Magnetic Microparticles for Phosphopeptide Affinity Enrichment
Díez, I. A., Govender, I. S., Naicker, P., Stoychev, S., Jordaan, J., & Jensen, O. N. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00508 · Cited by 62
Heterozygous Kit Mutants with Little or No Apparent Anemia Exhibit Large Defects in Overall Hematopoietic Stem Cell Function
Sharma, Y., Astle, C. M., & Harrison, D. E. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.10.001 · Cited by 63
Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor β Tyrosine Kinase Receptors in Synovial Sarcoma
Tamborini, E., Bonadiman, L., Greco, A., Gronchi, A., Riva, C., Bertulli, R., Casali, P. G., Pierotti, M. A., & Pilotti, S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0059 · Cited by 63
Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis
Saucier, C., Papavasiliou, V., Palazzo, A. F., Naujokas, M. A., Kremer, R. B., & Park, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205261 · Cited by 65
How does activation loop phosphorylation modulate catalytic activity in the cAMP-dependent protein kinase: a theoretical study
Cheng, Y., Zhang, Y., & McCammon, J. A. (2006) · Protein Science · doi:10.1110/ps.051852306 · Cited by 62
A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis
Eifert, C., Wang, X., Kokabee, L., Kourtidis, A., Jain, R., Gerdes, M. J., & Conklin, D. S. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22091 · Cited by 62
Profilin‐1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells
Das, T., Bae, Y., Wells, A. H., & Roy, P. S. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21618 · Cited by 62
Rabs and cancer cell motility
Tang, B. L., & Ng, E. L. (2009) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20376 · Cited by 62
H2O2 Production Downstream of FLT3 Is Mediated by p22phox in the Endoplasmic Reticulum and Is Required for STAT5 Signalling
Woolley, J. F., Naughton, R., Stanicka, J., Gough, D. R., Bhatt, L., Dickinson, B. C., Chang, C. J., & Cotter, T. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034050 · Cited by 64
Deletion of the Carboxyl Terminus of Tie2 Enhances Kinase Activity, Signaling, and Function
Niu, X.-L., Peters, K. G., & Kontos, C. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203995200 · Cited by 62
Diverse Ways to Control p27Kip1 Function: miRNAs Come into Play
le Sage, C., Nagel, R., & Agami, R. (2007) · Cell Cycle · doi:10.4161/cc.6.22.4900 · Cited by 62
A Juxtamembrane Tyrosine in the Colony Stimulating Factor-1 Receptor Regulates Ligand-induced Src Association, Receptor Kinase Function, and Down-regulation
Rohde, C. M., Schrum, J., & Lee, A. W. ‐. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314170200 · Cited by 66
Survey of Activated FLT3 Signaling in Leukemia
Gu, T.-L., Nardone, J., Wang, Y., Loriaux, M., Villén, J., Beausoleil, S. A., Tucker, M., Kornhauser, J. M., Ren, J., MacNeill, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019169 · Cited by 61
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK)
Edwards, L., Woo, J., Huxham, L. A., Verreault, M., Dragowska, W. H., Chiu, G. N. C., Rajput, A. B., Kyle, A. H., Kalra, J., Yapp, D. T. T., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0329 · Cited by 62
CSK Controls Retinoic Acid Receptor (RAR) Signaling: a RAR–c-SRC Signaling Axis Is Required for Neuritogenic Differentiation
Dey, N., De, P. K., Wang, M., Zhang, H., Dobrota, E. A., Robertson, K. A., & Durden, D. L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01352-06 · Cited by 62
Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming
Sukocheva, O. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020420 · Cited by 63
Assessing metastatic potential of breast cancer cells based on EGFR dynamics
Liu, Y., Chou, C., Kim, M., Vasisht, R., Kuo, Y.-A., Ang, P., Liu, C., Perillo, E. P., Chen, Y., Blocher, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37625-0 · Cited by 61
Epidermal growth factor receptor expression status in lung cancer correlates with its mutation
Suzuki, M., Shigematsu, H., Hiroshima, K., Iizasa, T., Nakatani, Y., Minna, J. D., Gazdar, A. F., & Fujisawa, T. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.08.007 · Cited by 62
The Slow Wallerian Degeneration Protein, WldS, Binds Directly to VCP/p97 and Partially Redistributes It within the Nucleus
Laser, H., Conforti, L., Morreale, G., Mack, T. G. A., Heyer, M., Haley, J. E., Wishart, T. M., Beirowski, B., Walker, S. A., Haase, G., et al. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-04-0375 · Cited by 61
Copine-III interacts with ErbB2 and promotes tumor cell migration
Heinrich, C., Keller, C., Boulay, A., Vecchi, M., Bianchi, M., Sack, R., Lienhard, S., Duss, S., Hofsteenge, J., & Hynes, N. E. (2009) · Oncogene · doi:10.1038/onc.2009.456 · Cited by 61
Computational modeling of brain tumors: discrete, continuum or hybrid?
Wang, Z., & Deisboeck, T. S. (2008) · Scientific Modeling and Simulation SMNS · doi:10.1007/s10820-008-9094-0 · Cited by 63
The Nonreceptor-Type Tyrosine Phosphatase PTPN13 Is a Tumor Suppressor Gene in Non–Small Cell Lung Cancer
Scrima, M., Marco, C. D., Vita, F. D., Fabiani, F., Franco, R., Pirozzi, G., Rocco, G., Malanga, D., & Viglietto, G. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.038 · Cited by 61
Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells
Lee, H. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.033 · Cited by 61
Chronic treatment with ginsenoside Rg3 induces Akt-dependent senescence in human glioma cells
Seong, S., Kim, S. Y., & Kim, S. S. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1604 · Cited by 60
The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification
Wang, H., Shi, T., Qian, W., Liu, T., Kagan, J., Srivastava, S., Smith, R. D., Rodland, K., & Camp, D. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1122529 · Cited by 66
Enzyme Inhibition and Bioapplications
Sharma, R. (2012) · InTech eBooks · doi:10.5772/1963 · Cited by 59
A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens
Alpízar, A., Marino, F., Ramos-Fernández, A., Lombardía, M., Jekő, A., Pazos, F., Paradela, A., Santiago, C. A., Heck, A. J. R., & Marcilla, M. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.063800 · Cited by 61
Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer’s Disease
Chen, D., Zhou, X. Z., & Lee, T. H. (2018) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892814666181218170257 · Cited by 61
Recent progress in the identification of BRAF inhibitors as anti-cancer agents
El‐Nassan, H. B. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.018 · Cited by 61
Shp1 in Solid Cancers and Their Therapy
Varone, A., Spano, D., & Corda, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00935 · Cited by 61
Ligand-independent and EGF receptor-supported transactivation: Lessons from β2-adrenergic receptor signalling
Drube, S., Stirnweiss, J., Valkova, C., & Liebmann, C. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.01.003 · Cited by 61
Bottle gourd rootstock-grafting affects nitrogen metabolism in NaCl-stressed watermelon leaves and enhances short-term salt tolerance
Yang, Y., Lu, X., Yan, B., Li, B., Sun, J., Guo, S., & Tezuka, T. (2013) · Journal of Plant Physiology · doi:10.1016/j.jplph.2012.12.013 · Cited by 60
Erlotinib inhibits T-cell-mediated immune response via down-regulation of the c-Raf/ERK cascade and Akt signaling pathway
Luo, Q., Gu, Y., Zheng, W., Wu, X., Gong, F., Gu, L., Sun, Y., & Xu, Q. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.12.011 · Cited by 60
Quantitative phosphoproteomics to characterize signaling networks
Rigbolt, K. T. G., & Blagoev, B. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.05.006 · Cited by 60
Toward understanding driving forces in membrane protein folding
Hong, H. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.031 · Cited by 63
Quantitative phosphoproteomics – an emerging key technology in signal‐transduction research
Schreiber, T. B., Mäusbacher, N., Breitkopf, S. B., Grundner‐Culemann, K., & Daub, H. (2008) · PROTEOMICS · doi:10.1002/pmic.200800132 · Cited by 59
Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
Hicks, J. W., VanBrocklin, H. F., Wilson, A. A., Houle, S., & Vasdev, N. (2010) · Molecules · doi:10.3390/molecules15118260 · Cited by 60
JNK-dependent Atg4 upregulation mediates asperphenamate derivative BBP-induced autophagy in MCF-7 cells
Li, Y., Luo, Q., Yuan, L., Miao, C., Xiaoshuo, M., Xiao, W., Li, J., Sun, T., & Ma, E. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.05.018 · Cited by 60
Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1
El‐Chaâr, D., Gagnon, A.-M., & Sorisky, A. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802554 · Cited by 60
Imatinib Mesylate Efficiently Achieves Therapeutic Intratumor Concentrations in Vivo but Has Limited Activity in a Xenograft Model of Small Cell Lung Cancer
Wolff, N. C., Randle, D. E., Egorin, M. J., Minna, J. D., & Ilaria, R. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0957-03 · Cited by 60
Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality
Shipitsin, M. V., Small, C. G., Giladi, E., Siddiqui, S., Choudhury, S. A., Hussain, S., Huang, Y. E., Chang, H., Rimm, D. L., Berman, D. M., et al. (2014) · Proteome Science · doi:10.1186/1477-5956-12-40 · Cited by 60
Self-citation
Mechanisms of TKI-induced diarrhea in cancer patients
Bowen, J. M. (2013) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e32835ec861 · Cited by 60
E2 superfamily of ubiquitin-conjugating enzymes: constitutively active or activated through phosphorylation in the catalytic cleft
Valimberti, I., Tiberti, M., Lambrughi, M., Šarčević, B., & Papaleo, E. (2015) · Scientific Reports · doi:10.1038/srep14849 · Cited by 60
Gaq proteins: molecular pharmacology and therapeutic potential
Kamato, D., Mitra, P., Davis, F. M., Osman, N., Chaplin, R., Cabot, P. J., Afroz, R., Thomas, W. G., Zheng, W., Kaur, H., et al. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2405-9 · Cited by 60
Efficient suppression of FGF-2-induced ERK activation by the cooperative interaction among mammalian Sprouty isoforms
Ozaki, K., Miyazaki, S., Tanimura, S., & Kohno, M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02711 · Cited by 60
TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity
Hori, H., Nagasawa, H., Ishibashi, M., Uto, Y., Hirata, A., Saijo, K., Ohkura, K., Kirk, K. L., & Uehara, Y. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00160-8 · Cited by 60
8p12 Stem Cell Myeloproliferative Disorder: the FOP-Fibroblast Growth Factor Receptor 1 Fusion Protein of the t(6;8) Translocation Induces Cell Survival Mediated by Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt/mTOR Pathways
Guasch, G., Ollendorff, V., Borg, J., Birnbaum, D., & Pébusque, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8129-8142.2001 · Cited by 58
Phosphatidylinositol 3‐Kinase and the Control of Endosome Dynamics: New Players Defined by Structural Motifs
Corvera, S. (2001) · Traffic · doi:10.1034/j.1600-0854.2001.21201.x · Cited by 60
A structural prospective for collagen receptors such as DDR and their binding of the collagen fibril
Orgel, J. P. R. O., & Madhurapantula, R. S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.04.008 · Cited by 59
The Factors and Pathways Regulating the Activation of Mammalian Primordial Follicles in vivo
Chen, Y., Yang, W., Shi, X., Zhang, C., Song, G., & Huang, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.575706 · Cited by 59
NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis
Nagasaka, M., & Ou, S. I. (2022) · Trends in cancer · doi:10.1016/j.trecan.2021.11.003 · Cited by 59
A New Family of Receptor Tyrosine Kinases with a Venus Flytrap Binding Domain in Insects and Other Invertebrates Activated by Aminoacids
Ahier, A., Rondard, P., Gouignard, N., Khayath, N., Huang, S., Trolet, J., Donoghue, D. J., Gauthier, M., Pin, J., & Dissous, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005651 · Cited by 59
Functional Characterization of Human Cancer-Derived TRKB Mutations
Geiger, T. R., Song, J., Rosado, A., & Peeper, D. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016871 · Cited by 58
Adhesion-Related Kinase Induction of Migration Requires Phosphatidylinositol-3-Kinase and Ras Stimulation of Rac Activity in Immortalized Gonadotropin-Releasing Hormone Neuronal Cells
Nielsen‐Preiss, S. M., Allen, M. P., Xu, M., Linseman, D. A., Pawlowski, J. E., Bouchard, R. J., Varnum, B. C., Heidenreich, K. A., & Wierman, M. E. (2007) · Endocrinology · doi:10.1210/en.2007-0039 · Cited by 62
Death and dessert: nutrient signalling pathways and ageing
Alic, N., & Partridge, L. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.07.006 · Cited by 60
Basic helix‐loop‐helix transcription factor DEC1 negatively regulates cyclin D1
BHAWAL, U. K., Sato, F., Arakawa, Y., Fujimoto, K., Kawamoto, T., Tanimoto, K., Ito, Y., Sasahira, T., Sakurai, T., Kobayashi, M., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2878 · Cited by 59
Defining the blueprint of the cancer genome
Velculescu, V. E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn096 · Cited by 59
PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment
Cenciarelli, C., Marei, H. E. S., Zonfrillo, M., Pierimarchi, P., Paldino, E., Casalbore, P., Felsani, A., Vescovi, A. L., Maira, G., & Mangiola, A. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-247 · Cited by 61
An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion.
Wang, Y.-T., Tsai, C.-F., Hong, T.-C., Tsou, C.-C., Lin, P.-Y., Pan, S.-H., Hong, T., Yang, P.-C., Sung, T.-Y., Hsu, W.-L., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100394u · Cited by 66
The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer
Cardoso, H. J., Figueira, M. I., & Socorro, S. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0399-1 · Cited by 62
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Remmerie, M., & Janssens, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00462 · Cited by 60
IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription
Mireuta, M., Darnel, A., & Pollak, M. (2010) · Growth Factors · doi:10.3109/08977191003745472 · Cited by 55
Nuclear receptor superfamily: Principles of signaling
Germain, P., Altucci, L., Bourguet, W., Rochette-Egly, C., & Gronemeyer, H. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375111619 · Cited by 53

Authors: Blume-Jensen, P., & Hunter, T.
Affiliations: Salk Institute for Biological Studies (US)
ORCID: Hunter, Tony
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2001-05-01
Volume: 411
Issue: 6835
Pages: 355-365
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/35077225
OpenAlex: W1639582946
Cited by: 3,738
References: 93
Citations by year: 2026: 48 · 2025: 69 · 2024: 87 · 2023: 102 · 2022: 103 · 2021: 114 · 2020: 121 · 2019: 118 · 2018: 105 · 2017: 119 · 2016: 131 · 2015: 156 · 2014: 186 · 2013: 185 · 2012: 200
FWCI: 12.95
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: tyrosine kinase, oncogenic signaling, signal transduction, phosphatidylinositol 3-kinase, Akt, p70 S6 kinase, mTOR, kinase autoinhibition, malignant transformation, human malignancies
MeSH terms: Animals, Humans, Mutation, Neoplasms, Oncogenes, Protein-Tyrosine Kinases, Signal Transduction, Oncogene Proteins, Retroviridae Proteins, Oncogenic, Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, Receptor Protein-Tyrosine Kinases, Oncogene Protein v-akt

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oncogenic kinase signalling.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks